IN VIVO DETECTION OF AMYLOID DEPOSITION USING F AGNETIC RESONANCE IMAGING WITH A F-CONTAINING CURCUMIN DERIVATIVE IN A MOUSE MODEL OF ALZHEIMER’S DISEASE
暂无分享,去创建一个
D. Yanagisawa | S. Morikawa | T. Inubushi | I. Tooyama | S. Morikawa | A. Shiino | T. Amatsubo | H. Taguchi | M. Urushitani | N. Shirai | K. Hirao | T. Inubushi | A. Shiino | D. Yanagisawa | T. Amatsubo | H. Taguchi | M. Urushitani | N. Shirai | K. Hirao | T. Inubushi | I. Tooyama | Daijiro Yanagisawa | Tomone Amatsubo | Hiroyasu Taguchi | Makoto Urushitani | M. Urushitani | H. Taguchi | S. Morikawa | N. Shirai | K. Hirao | I. TOOYAMAa
[1] Shigehiro Morikawa,et al. Relationship between the tautomeric structures of curcumin derivatives and their Abeta-binding activities in the context of therapies for Alzheimer's disease. , 2010, Biomaterials.
[2] J. Salvador,et al. The dark side of curcumin , 2010, International journal of cancer.
[3] C. Jack,et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.
[4] Anna Moore,et al. Design, synthesis, and testing of difluoroboron-derivatized curcumins as near-infrared probes for in vivo detection of amyloid-beta deposits. , 2009, Journal of the American Chemical Society.
[5] A. Fagan,et al. Multimodal techniques for diagnosis and prognosis of Alzheimer's disease , 2009, Nature.
[6] C. Mancuso,et al. Curcumin in clinical practice: myth or reality? , 2009, Trends in pharmacological sciences.
[7] S. Morikawa,et al. Trifluoromethoxy-benzylated ligands improve amyloid detection in the brain using 19F magnetic resonance imaging , 2009, Neuroscience Research.
[8] J. Pettegrew,et al. Clinically Relevant Concentration Determination of Inhaled Anesthetics (Halothane, Isoflurane, Sevoflurane, and Desflurane) by 19F NMR , 2008, Cell Biochemistry and Biophysics.
[9] M. Garwood,et al. Selective Contrast Enhancement of Individual Alzheimer’s Disease Amyloid Plaques Using a Polyamine and Gd-DOTA Conjugated Antibody Fragment Against Fibrillar Aβ42 for Magnetic Resonance Molecular Imaging , 2008, Pharmaceutical Research.
[10] B. Aggarwal,et al. Curcumin as "Curecumin": from kitchen to clinic. , 2008, Biochemical pharmacology.
[11] V. Mok,et al. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. , 2008, Journal of clinical psychopharmacology.
[12] M. Ramirez-Alvarado,et al. In vivo targeting of antibody fragments to the nervous system for Alzheimer’s disease immunotherapy and molecular imaging of amyloid plaques , 2007, Journal of neurochemistry.
[13] Kazuhiko Yanai,et al. 2-(2-[2-Dimethylaminothiazol-5-yl]Ethenyl)-6- (2-[Fluoro]Ethoxy)Benzoxazole: A Novel PET Agent for In Vivo Detection of Dense Amyloid Plaques in Alzheimer's Disease Patients , 2007, Journal of Nuclear Medicine.
[14] K. Takata,et al. Microglial transplantation increases amyloid‐β clearance in Alzheimer model rats , 2007 .
[15] Eun Kyoung Ryu,et al. Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for beta-amyloid plaque imaging. , 2006, Journal of medicinal chemistry.
[16] Y. Kitamura,et al. Comparison of MR images and histochemical localization of intra-arterially administered microglia surrounding beta-amyloid deposits in the rat brain. , 2006, Histology and histopathology.
[17] Nobuhisa Iwata,et al. 19F and 1H MRI detection of amyloid β plaques in vivo , 2005, Nature Neuroscience.
[18] Fusheng Yang,et al. Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo* , 2005, Journal of Biological Chemistry.
[19] M. Pirmohamed,et al. Phase I Clinical Trial of Oral Curcumin , 2004, Clinical Cancer Research.
[20] Agneta Nordberg,et al. PET imaging of amyloid in Alzheimer's disease , 2004, The Lancet Neurology.
[21] G. Curran,et al. Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques. , 2004, Biochemistry.
[22] W. Klunk,et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.
[23] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[24] G. Cole,et al. The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse , 2001, The Journal of Neuroscience.
[25] S. Jee,et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. , 2001, Anticancer Research.
[26] S. Younkin,et al. Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.
[27] V. Simplaceanu,et al. Intravenous anesthetic diazepam does not induce amyloid-beta peptide oligomerization but diazepam co-administered with halothane oligomerizes amyloid-beta peptide: an NMR study. , 2010, Journal of Alzheimer's disease : JAD.
[28] D. Yanagisawa,et al. Amyloid imaging using high-field magnetic resonance. , 2010, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[29] P. Mandal,et al. NMR investigations of amyloid-β peptide interactions with propofol at clinically relevant concentrations with and without aqueous halothane solution. , 2010, Journal of Alzheimer's disease : JAD.